Vincerx Pharma, Inc. Accounts Payable
Vincerx Pharma, Inc. had Accounts Payable of $2.27 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-05-15
- 2025-03-31: Accounts Payable, Current $2.27M.
- 2024-12-31: Accounts Payable, Current $2.03M.
- 2024-09-30: Accounts Payable, Current $1.96M.
- 2024-06-30: Accounts Payable, Current $1.54M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-03-31 | $2.27M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.03M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $1.96M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.54M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.31M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.50M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $3.06M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.53M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $6.17M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.07M 10-K · filed 2024-03-29 | $3.06M 10-K · filed 2023-03-28 |
| 2022-09-30 | $4.39M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.12M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.39M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.02M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $2.26M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.83M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $461.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $491.00K 10-K · filed 2022-03-29 | |
| 2019-12-31 | $35.00K 10-K/A · filed 2021-05-14 |